Clinical trial
Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins
NCT00131586 is registered in ClinicalTrials.gov with AHS Cancer Control Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins
- Lead sponsor
- AHS Cancer Control Alberta
- Phase
- Observational
- Overall status
- Terminated
- Start date
- April 30, 2003
- Completion date
- February 28, 2009
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer, lung cancer